Christopher Patusky, Director at UNITED THERAPEUTICS Corp (UTHR), bought 21 shares at $82.83 ($2K) on 2019-06-10, disclosed to the SEC on 2023-05-03.
Seasonal purchase ($2k) by Director — this insider has traded UTHR in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $130.24 | 3 | $391 | 16.1% |
| 2 | $128.35 | 3 | $385 | 15.9% |
| 3 | $126.20 | 5 | $631 | 26.0% |
| 4 | $114.06 | 6 | $684 | 28.3% |
| 5 | $82.83 | 4 | $331 | 13.7% |
| Total | $115.35 avg | 21 |
| $2K |
| 100% |
| Filing → |
| UTHR | SELL | 2025-12-16 | $496K | — | Filing → |
| UTHR | SELL | 2025-03-20 | $3.0M | — | Filing → |
| UTHR | SELL | 2025-01-13 | $3.3M | — | Filing → |